Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

Hyperthermia generated by interstitial probe(s) is a specialized medical procedure aimed at elevating the temperature of tumor cells while minimizing damage to the surrounding healthy tissue. This technique utilizes interstitially placed applicators or probes that generate heat through various methods, including microwave, radiofrequency, or ultrasound energy. The fundamental principle behind this procedure is that tumor cells exhibit a higher sensitivity to increased temperatures compared to normal cells. By raising the temperature of the tumor cells, the procedure can enhance the efficacy of concurrent treatments such as radiation and chemotherapy, as well as potentially stimulate the immune system's components that contribute to the destruction of abnormal cells. Interstitial hyperthermia therapy is particularly beneficial for treating tumors located deep within the body, such as those found in the lungs or abdominal organs. During the procedure, the patient is placed under anesthesia, and the applicators or probes are carefully inserted into the tumor with the assistance of imaging techniques like x-ray or ultrasound guidance. Once positioned, a heat source is introduced into the applicators or probes, allowing the targeted area to be heated to a predetermined temperature. Following the treatment session, the probes are removed. The CPT® Code 77610 specifically reports interstitial hyperthermia therapy utilizing five or fewer interstitial applicators, while CPT® Code 77615 is designated for cases involving more than five applicators or probes.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure of hyperthermia generated by interstitial probe(s) is indicated for the treatment of various tumor types, particularly when they are located deep within the body. The following conditions may warrant the use of this procedure:

  • Deep-seated tumors Tumors located in organs such as the lungs or abdominal cavity that are not easily accessible through traditional surgical methods.
  • Enhancement of radiation therapy Patients undergoing radiation treatment who may benefit from increased tumor sensitivity to radiation through elevated temperatures.
  • Support for chemotherapy Tumors that may respond better to chemotherapy when combined with hyperthermia, potentially improving treatment outcomes.
  • Immune system stimulation Conditions where stimulating the immune response against tumor cells is desired, as elevated temperatures may aid in this process.

2. Procedure

The procedure for hyperthermia generated by interstitial probe(s) involves several critical steps to ensure effective treatment. Each step is designed to maximize the therapeutic effects while minimizing risks to surrounding healthy tissue.

  • Step 1: Patient Preparation The patient is first prepared for the procedure, which includes obtaining informed consent and ensuring that they are under appropriate anesthesia to minimize discomfort during the treatment.
  • Step 2: Imaging Guidance Using imaging techniques such as x-ray or ultrasound, the physician identifies the precise location of the tumor. This step is crucial for the accurate placement of the interstitial applicators or probes.
  • Step 3: Insertion of Applicators/Probes Once the tumor is located, the physician carefully inserts the interstitial applicators or probes into the tumor. This is done with precision to ensure that the heat will be effectively delivered to the targeted area.
  • Step 4: Heat Application After the applicators or probes are in place, a heat source is introduced into them. The targeted area is then heated to the desired temperature, which is determined based on the specific treatment plan and the characteristics of the tumor.
  • Step 5: Monitoring Throughout the procedure, the patient's vital signs and the temperature of the targeted area are monitored to ensure safety and effectiveness. Adjustments may be made as necessary to achieve optimal results.
  • Step 6: Removal of Probes At the conclusion of the treatment session, the applicators or probes are carefully removed from the patient. Post-procedure care is then initiated as needed.

3. Post-Procedure

After the hyperthermia treatment, patients may require monitoring for any immediate side effects or complications. Common post-procedure care includes assessing the insertion sites for signs of infection or adverse reactions. Patients may experience localized discomfort or swelling, which can be managed with appropriate pain relief measures. Follow-up appointments are typically scheduled to evaluate the effectiveness of the treatment and to determine if additional sessions are necessary. It is essential for healthcare providers to provide patients with clear instructions regarding any activity restrictions or care requirements following the procedure to ensure optimal recovery and outcomes.

Short Descr HYPERTHERMIA NTRSTL PRB 5/<
Medium Descr HYPERTHERMIA INTERSTITIAL PROBE 5/< APPLICATORS
Long Descr Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators
Status Code Restricted Coverage
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Not Discounted when Multiple
ASC Payment Indicator Radiology service paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS relative payment weight.
Type of Service (TOS) 6 - Therapeutic Radiology
Berenson-Eggers TOS (BETOS) P7B - Oncology - other
MUE 1
CCS Clinical Classification 211 - Therapeutic radiology
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
GC This service has been performed in part by a resident under the direction of a teaching physician
Date
Action
Notes
2025-01-01 Changed Short Description changed.
2017-01-01 Changed Moderate (Conscious) Sedation flag removed. See new Moderate Sedation category.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"